N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

C23H27N7O — CID 123502812

IUPACN-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCC1C=CC(n2nc(C3(C)CCNCC3)cc2NC(=O)c2cnn3cccnc23)=CC1
InChIInChI=1S/C23H27N7O/c1-16-4-6-17(7-5-16)30-20(14-19(28-30)23(2)8-11-24-12-9-23)27-22(31)18-15-26-29-13-3-10-25-21(18)29/h3-4,6-7,10,13-16,24H,5,8-9,11-12H2,1-2H3,(H,27,31)
InChIKeyGEBWIOVRQXWBBQ-UHFFFAOYSA-N
MW417.52 g/mol
LogP3.26
Rot. Bonds4

About N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 123502812) has the molecular formula C23H27N7O and a molecular weight of 417.52 g/mol. Its IUPAC name is N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.

Molecular Properties

Compound NameN-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID123502812
Molecular FormulaC23H27N7O
Molecular Weight417.52 g/mol
Exact Mass417.23
IUPAC NameN-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCC1C=CC(n2nc(C3(C)CCNCC3)cc2NC(=O)c2cnn3cccnc23)=CC1
InChIInChI=1S/C23H27N7O/c1-16-4-6-17(7-5-16)30-20(14-19(28-30)23(2)8-11-24-12-9-23)27-22(31)18-15-26-29-13-3-10-25-21(18)29/h3-4,6-7,10,13-16,24H,5,8-9,11-12H2,1-2H3,(H,27,31)
InChIKeyGEBWIOVRQXWBBQ-UHFFFAOYSA-N
XLogP3.26
TPSA89.14 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500417.52
LogP ≤ 53.26
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 123502812) is N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is CC1C=CC(n2nc(C3(C)CCNCC3)cc2NC(=O)c2cnn3cccnc23)=CC1.
What is the InChIKey of N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is GEBWIOVRQXWBBQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H27N7O/c1-16-4-6-17(7-5-16)30-20(14-19(28-30)23(2)8-11-24-12-9-23)27-22(31)18-15-26-29-13-3-10-25-21(18)29/h3-4,6-7,10,13-16,24H,5,8-9,11-12H2,1-2H3,(H,27,31).
What are the key properties of N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 417.52 g/mol, XLogP of 3.26, 4 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-(4-methylcyclohexa-1,5-dien-1-yl)-3-(4-methylpiperidin-4-yl)pyrazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 123502812), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).